Amedisys Inc ( (AMED) ) has released its Q3 earnings. Here is a breakdown of the information Amedisys Inc presented to its investors. Amedisys, ...
The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.
UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) leaders are reportedly expected to meet with officials from the Department of Justice over the next week to discuss their pending deal. The ...
BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care ...
The company’s ROE of 17.8% compares favorably with the industry’s 8.2%. Amedisys: Amedisys, a well-known provider of home health, hospice and high-acuity care, reported its second-quarter 2024 ...
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Amedisys (AMED).
Australia has committed up to $600 million over a decade to bolster PNG's pitch to secure a team in the competition, with the NRL set to make a final decision in coming weeks. But the ABC revealed ...